Regular articleCA 15-3 as a tumor marker in gynecological malignancies
References (21)
- et al.
A survey of tumor markers in patients with squamous cell carcinoma of the uterine cervix
Gynecol. Oncol.
(1982) - et al.
The use of CA 125 in the diagnosis and management of endometriosis
Fertil. Steril.
(1986) - et al.
CA 125 in gynecologic practice
Amer. J. Obstet. Gynecol.
(1986) - et al.
Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium and endocervix
Amer. J. Obstet. Gynecol.
(1984) - et al.
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
N. Engl. J. Med.
(1983) - et al.
Multiple biochemical markers in patients with gynecologic malignancies
Cancer
(1980) - et al.
Serum CA 125 levels in epithelial ovarian cancer: Relation with findings at second-look operations and their role in the detection of tumor recurrence
Brit. J. Obstet. Gynecol.
(1987) - et al.
Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy
Obstet. Gynecol.
(1981) - et al.
Immunohistochemical localization of alpha-fetoprotein (AFP) in germ cell tumors: Evidence of AFP production by tissues different from endodermal sinus tumor
Oncology
(1981) - et al.
Carcinoembryonic antigen in cancer of the female reproductive system
Cancer
(1977)
Cited by (45)
Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial
2019, American Journal of Obstetrics and GynecologyCitation Excerpt :CA125 and CA 15-3 have been evaluated as potential screening biomarkers for endometrial cancer. CA 15-3 levels, however, are found to be elevated in only 36% of endometrial cancer patients, and CA125 has been shown to be elevated in 19–40% of endometrial cancer patients.27,28 Moreover, increased levels of CA125 may also be related to inflammatory conditions not related to endometrial cancer.
Serum tumour markers in gynaecological cancers
2010, MaturitasPreoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer
2007, Gynecologic OncologyCitation Excerpt :Serum tumor markers, such as CA125 and CA15-3, have previously been evaluated as potential detection and prognostic indicators both for epithelial ovarian cancer and endometrial cancer. CA15-3 levels were found to be elevated in only 36% of endometrial cancer patients [13]. CA125 has been reported to be elevated in 19% to 40% of endometrial cancer patients [14–16].
The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy
2021, International Journal of Molecular Sciences